Advertisement
Advertisement
GDRX
GoodRx Holdings, Inc. Class A Common Stock
3.51
USDSponsored
+0.02
+0.57%
Nov 06, 15:58 UTC -5
Closed
After-Market
3.58
+0.07
+1.91%
GoodRx Holdings, Inc. Class A Common Stock (GDRX) Earnings
GDRX Earnings Reports
Positive Surprise Ratio
GDRX beat 12 of 24 last estimates.
50%
Next Report
Next Week
Date of Next Report
Nov 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
$206.14M
/$0.07
Implied change from Q2 26 (Revenue/ EPS)
+2.86%
/-12.50%
Implied change from Q3 25 (Revenue/ EPS)
+5.16%
/-12.50%
GoodRx Holdings, Inc. Class A Common Stock earnings per share and revenue
On Aug 05, 2026, GDRX reported earnings of 0.08 USD per share (EPS) for Q2 26, missing the estimate of 0.08 USD, resulting in a -0.99% surprise. Revenue reached 200.41 million, compared to an expected 197.03 million, with a 1.72% difference. The market reacted with a +13.76% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of 0.07 USD, with revenue projected to reach 206.14 million USD, implying an decrease of -12.50% EPS, and increase of 2.86% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Sonida Senior Living, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.54
Actual
-$0.65
Surprise
-19.11%
Nutex Health Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$5.82
Actual
$5.71
Surprise
-1.93%
Omada Health, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.01
Actual
$0.17
Surprise
+900.00%
CryoPort, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.17
Actual
-$0.25
Surprise
-38.97%
Shoulder Innovations, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.50
Actual
-$0.34
Surprise
+32.57%
Biodesix, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.76
Actual
-$0.75
Surprise
+1.77%
SkinHealth Systems Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$1.30
Actual
-$0.14
Surprise
+89.28%
Natera, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.29
Actual
-$0.39
Surprise
-30.65%
Viatris Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.64
Actual
$0.71
Surprise
+9.31%
Solventum Corporation
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.38
Actual
$1.45
Surprise
+5.02%
FAQ
What were GoodRx Holdings, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, GoodRx Holdings, Inc. Class A Common Stock reported EPS of $0.08, missing estimates by -0.99%, and revenue of $200.41M, 1.72% above expectations.
How did the market react to GoodRx Holdings, Inc. Class A Common Stock's Q2 2026 earnings?
The stock price moved up 13.76%, changed from $3.27 before the earnings release to $3.72 the day after.
When is GoodRx Holdings, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Nov 10, 2026.
What are the forecasts for GoodRx Holdings, Inc. Class A Common Stock's next earnings report?
Based on --
analysts, GoodRx Holdings, Inc. Class A Common Stock is expected to report EPS of $0.07 and revenue of $206.14M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.